How Kayentis Reduces The CO2 Emissions Of Your eCOA Projects
Source: Kayentis

In 2020, we implemented a carbon neutral program for all our clinical trials Our goal? To reduce project CO2 emissions without impacting cost, quality or timelines.
Kayentis aims to be a sustainable company in a sustainable world. As such, we support the pharma community’s key ambitions to protect the environment.
To learn more about Kayentis, visit their Clinical Leader page.
access the Brochure!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Clinical Leader? Subscribe today.
Subscribe to Clinical Leader
X
Subscribe to Clinical Leader
This website uses cookies to ensure you get the best experience on our website. Learn more